These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17075229)

  • 1. Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.
    Gu M; Wilton R; Stevens FJ
    Contrib Nephrol; 2007; 153():156-81. PubMed ID: 17075229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin synthesis in primary and myeloma amyloidosis.
    Preud'homme JL; Ganeval D; Grünfeld JP; Striker L; Brouet JC
    Clin Exp Immunol; 1988 Sep; 73(3):389-94. PubMed ID: 3145161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
    Solomon A; Weiss DT; Macy SD; Antonucci RA
    Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The V kappa III subgroup light chain proteins in AL amyloidosis & autoimmune diseases.
    Alim MA; Hara Y; Kaji H; Shinoda T
    Indian J Med Res; 2001 Jul; 114():30-5. PubMed ID: 11762204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of amyloidosis complicated by IgU/lambda/-myeloma multiplex].
    Husz S; Török L; Kovács L; Szabó E; Simon N
    Z Hautkr; 1979 Jul; 54(13):585-9. PubMed ID: 113946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
    Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
    Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
    Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
    PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Light chain myeloma or the pitfalls of myeloma diagnosis].
    Zufferey P; Pugin P; Regamey C
    Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
    Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
    Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amyloidosis of juvenile rheumatoid arthritis - comparative studies in Polish and American children II. Serum immunoglobulins, kappa and lambda light chain and C3 levels.
    Filipowicz-Sosnowska AM; Baum J
    J Rheumatol; 1979; 6(3):277-85. PubMed ID: 114636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A very unusual case of amyloidosis].
    Jouvin MH; Nochy D; Bruneval P; Guettier C; Druet P; Bariéty J
    Nephrologie; 1985; 6(3):159-62. PubMed ID: 3935940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AL-amyloidosis is underdiagnosed in renal biopsies.
    Novak L; Cook WJ; Herrera GA; Sanders PW
    Nephrol Dial Transplant; 2004 Dec; 19(12):3050-3. PubMed ID: 15507480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of V kappa I and V lambda II light chain genes in the expressed B-cell repertoire.
    Manheimer-Lory A; Irigoyen M; Gaynor B; Monhian R; Splaver A; Diamond B
    Ann N Y Acad Sci; 1995 Sep; 764():301-11. PubMed ID: 7486540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
    Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
    J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome.
    El Hamel C; Thierry A; Trouillas P; Bridoux F; Carrion C; Quellard N; Goujon JM; Aldigier JC; Gombert JM; Cogné M; Touchard G
    Nephrol Dial Transplant; 2010 Sep; 25(9):2982-90. PubMed ID: 20356978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal rheumatoid factor (IgG lambda) its association with amyloid deposits containing lambda light chains.
    Singh G; Myerowitz RL; Chervenick PA; Kelly RH
    Arch Pathol Lab Med; 1981 Nov; 105(11):586-9. PubMed ID: 6794541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid sequence diversity in mouse lambda 2 variable regions.
    Elliott BW; Eisen HN; Steiner LA
    J Immunol; 1984 Nov; 133(5):2757-61. PubMed ID: 6434637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.